X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10633) 10633
Publication (679) 679
Book Review (170) 170
Magazine Article (34) 34
Book / eBook (24) 24
Book Chapter (7) 7
Conference Proceeding (6) 6
Paper (4) 4
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9099) 9099
delayed-action preparations (8144) 8144
female (5668) 5668
male (5590) 5590
index medicus (4374) 4374
adult (4181) 4181
middle aged (3895) 3895
pharmacology & pharmacy (3131) 3131
aged (2503) 2503
treatment outcome (1883) 1883
animals (1828) 1828
double-blind method (1720) 1720
adolescent (1345) 1345
delayed-action preparations - administration & dosage (1244) 1244
psychiatry (1093) 1093
administration, oral (1074) 1074
dose-response relationship, drug (1063) 1063
drug administration schedule (1033) 1033
time factors (973) 973
pharmacokinetics (944) 944
efficacy (926) 926
drug delivery systems (898) 898
double-blind (852) 852
drugs (775) 775
drug therapy (742) 742
analysis (716) 716
delayed-action preparations - chemistry (710) 710
delayed-action preparations - adverse effects (709) 709
drug therapy, combination (703) 703
young adult (696) 696
schizophrenia - drug therapy (666) 666
safety (656) 656
delayed-action preparations - therapeutic use (649) 649
care and treatment (636) 636
aged, 80 and over (620) 620
child (595) 595
antipsychotic agents - administration & dosage (591) 591
medicine, general & internal (586) 586
tablets (585) 585
therapy (582) 582
clinical trials as topic (576) 576
antipsychotic agents - adverse effects (570) 570
cross-over studies (570) 570
clinical neurology (559) 559
prospective studies (551) 551
delayed-action preparations - pharmacokinetics (515) 515
rats (513) 513
controlled release (499) 499
dosage and administration (494) 494
chemistry, pharmaceutical (492) 492
hypertension - drug therapy (488) 488
analgesics, opioid - administration & dosage (485) 485
schizophrenia (482) 482
microspheres (481) 481
medicine & public health (477) 477
follow-up studies (471) 471
injections, intramuscular (469) 469
solubility (447) 447
drug combinations (444) 444
internal medicine (444) 444
nanoparticles (444) 444
pharmacology/toxicology (444) 444
research (444) 444
antipsychotic agents - therapeutic use (443) 443
vehicles (438) 438
biological availability (416) 416
particle size (413) 413
randomized controlled trials as topic (413) 413
blood pressure - drug effects (411) 411
mice (411) 411
analgesics, opioid - adverse effects (403) 403
chemistry, multidisciplinary (386) 386
health aspects (374) 374
management (365) 365
clinical trials (363) 363
drug-delivery (363) 363
pharmacotherapy (361) 361
in-vitro (360) 360
kinetics (356) 356
quality of life (355) 355
area under curve (354) 354
neurosciences (341) 341
psychiatric status rating scales (337) 337
pain (336) 336
cancer (332) 332
trial (329) 329
attention deficit disorder with hyperactivity - drug therapy (328) 328
drug carriers - chemistry (327) 327
severity of illness index (323) 323
chronic disease (321) 321
pain - drug therapy (317) 317
article (314) 314
delivery (311) 311
materials science, biomaterials (308) 308
pregnancy (306) 306
drug compounding (303) 303
polymers (299) 299
formulation (297) 297
retrospective studies (291) 291
pharmacology (290) 290
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9819) 9819
German (329) 329
French (144) 144
Japanese (71) 71
Russian (65) 65
Spanish (54) 54
Italian (37) 37
Danish (29) 29
Chinese (28) 28
Polish (23) 23
Hungarian (14) 14
Norwegian (13) 13
Dutch (12) 12
Swedish (12) 12
Bulgarian (9) 9
Czech (8) 8
Hebrew (6) 6
Croatian (4) 4
Portuguese (3) 3
Romanian (3) 3
Slovak (3) 3
Finnish (2) 2
Turkish (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2015, Volume 17, Issue 4, pp. 386 - 394
Journal Article
Drug Development and Industrial Pharmacy, ISSN 0363-9045, 11/2013, Volume 39, Issue 11, pp. 1599 - 1617
Amongst the various routes of drug delivery, the field of ocular drug delivery is one of the most interesting and challenging endeavors facing the... 
in-situ gelling system | drug delivery systems | Bioavailability | particulate systems | Drug delivery systems | Particulate systems | GELLING SYSTEM | CHEMISTRY, MEDICINAL | LIPID NANOPARTICLES SLN | CHITOSAN NANOPARTICLES | TIMOLOL MALEATE | IN-VITRO | CYCLOSPORINE-A | SUSTAINED OPHTHALMIC DELIVERY | DRY EYE | SODIUM HYALURONATE EYEDROPS | PHARMACOLOGY & PHARMACY | LIPOSOMES | Prodrugs - administration & dosage | Viscosity | Administration, Ophthalmic | Cyclodextrins - adverse effects | Humans | Excipients - adverse effects | Biological Availability | Prescription Drugs - adverse effects | Delayed-Action Preparations - administration & dosage | Excipients - chemistry | Chemical Phenomena | Cyclodextrins - chemistry | Delayed-Action Preparations - pharmacokinetics | Eye - drug effects | Eye - metabolism | Drug Compounding - methods | Adhesiveness | Eye - anatomy & histology | Solubility | Eye Diseases - metabolism | Prescription Drugs - administration & dosage | Ocular Physiological Phenomena - drug effects | Prodrugs - adverse effects | Animals | Prescription Drugs - therapeutic use | Delayed-Action Preparations - adverse effects | Prodrugs - pharmacokinetics | Eye Diseases - drug therapy | Delayed-Action Preparations - therapeutic use | Drug Compounding - trends | Prodrugs - therapeutic use | Drug Delivery Systems - trends | Drug Delivery Systems - adverse effects | Eye Diseases - physiopathology | Prescription Drugs - pharmacokinetics | Eye - physiopathology
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 16, pp. 1229 - 1236
Journal Article
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 04/2015, Volume 91, pp. 91 - 102
The aim of the present study was to develop a novel strategy to deliver intracellularly the peptide GSE24.2 for the treatment of Dyskeratosis congenita (DC)... 
Dyskeratosis congenita | GSE24.2 peptide | Cell-penetrating peptides | Biodegradable nanoparticles | Polycations | Telomerase reactivation | Dyskeratosis congenital | PHAGOCYTOSIS | SOLID-PHASE SYNTHESIS | NANOENCAPSULATION | MICROPARTICLES | PLGA-BASED NANOPARTICLES | MAINTENANCE | DYSKERATOSIS-CONGENITA | MUTATION | PHARMACOLOGY & PHARMACY | BIOMEDICAL APPLICATIONS | PENETRATING PEPTIDES | Recombinant Proteins - therapeutic use | Dyskeratosis Congenita - drug therapy | Nanoparticles - chemistry | Biocompatible Materials - chemistry | Humans | Enzyme Reactivators - administration & dosage | Polyethylene Glycols - chemistry | Telomerase - deficiency | Biological Transport | Drug Compounding | Telomerase - metabolism | Peptide Fragments - genetics | Cell Survival - drug effects | Lactic Acid - chemistry | Polyamines - chemistry | Enzyme Reactivators - chemistry | Recombinant Proteins - chemistry | Nuclear Proteins - chemistry | Peptide Fragments - chemistry | Delayed-Action Preparations - adverse effects | Telomerase - chemistry | Delayed-Action Preparations - therapeutic use | Drug Liberation | Lactic Acid - adverse effects | Polyglactin 910 - adverse effects | Mice | Peptide Fragments - adverse effects | Biocompatible Materials - adverse effects | Drug Delivery Systems - adverse effects | Polyamines - adverse effects | Polyglycolic Acid - adverse effects | Polyethylene Glycols - adverse effects | Delayed-Action Preparations - chemistry | Nanoparticles - adverse effects | Recombinant Proteins - adverse effects | Cell Cycle Proteins - administration & dosage | Delayed-Action Preparations - administration & dosage | Cell Cycle Proteins - chemistry | Nuclear Proteins - administration & dosage | Cell-Penetrating Peptides - adverse effects | Chemical Phenomena | Cell Cycle Proteins - genetics | Polyglactin 910 - chemistry | Protein Stability | Nuclear Proteins - genetics | Cell-Penetrating Peptides - chemistry | Cell Line | Cell Cycle Proteins - adverse effects | Drug Stability | Peptide Fragments - administration & dosage | Cells, Cultured | Nuclear Proteins - adverse effects | Recombinant Proteins - administration & dosage | Enzyme Reactivators - therapeutic use | Animals | Enzyme Reactivators - adverse effects | Polyglycolic Acid - chemistry | Peptides | Telomerase
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2010, Volume 142, Issue 1, pp. 40 - 46
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 11/2014, Volume 475, Issue 1-2, pp. 60 - 68
Polymeric micelles hold great promise in nanocarrier delivery systems for anticancer drugs. A mixed micelle composed of deoxycholic acid-modified... 
Mixed micelles | PEG-PDLLA | Chitooligosaccharide | Polymeric micelles | Paclitaxel | VITRO | ZEBRAFISH | DRUG-DELIVERY | CHITOSAN | NANOCARRIERS | NANOPARTICLES | FORMULATIONS | TAXOL | IN-VIVO | PHARMACOLOGY & PHARMACY | Drug Carriers - adverse effects | Lung Neoplasms - drug therapy | Drug Carriers - therapeutic use | Nanoparticles - chemistry | Humans | Lung Neoplasms - metabolism | Deoxycholic Acid - chemistry | Drug Carriers - administration & dosage | Polyethylene Glycols - adverse effects | Lung Neoplasms - pathology | Male | Polyethylene Glycols - chemistry | Paclitaxel - pharmacokinetics | Nanoparticles - adverse effects | Delayed-Action Preparations - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Deoxycholic Acid - adverse effects | Chitin - analogs & derivatives | Micelles | Oligosaccharides - chemistry | Surface Properties | Delayed-Action Preparations - pharmacokinetics | Chitin - adverse effects | Drug Compounding | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - adverse effects | Polyesters - adverse effects | Specific Pathogen-Free Organisms | Paclitaxel - adverse effects | Chitin - chemistry | Oligosaccharides - adverse effects | Zebrafish | Random Allocation | Paclitaxel - therapeutic use | Rats, Sprague-Dawley | Xenograft Model Antitumor Assays | Polyesters - chemistry | Animals | Delayed-Action Preparations - adverse effects | Tumor Burden - drug effects | Mice, Nude | Cell Line, Tumor | Delayed-Action Preparations - therapeutic use | Drug Carriers - pharmacokinetics | Ethylene glycol | Deoxycholic acid
Journal Article